| abstract |
The present invention relates to a transdermal agent comprising an active agent component comprising a polymer matrix and an abuseable drug substance, an overlay backing, a porous material, and an antagonist reservoir comprising an antagonist to the abuseable drug substance. Comprising a shape. The porous material is adjacent to the antagonist reservoir and is in fluid communication with the skin contacting surface defined by the active agent component. In one embodiment, the device comprises a barrier layer inserted between the active agent component and the antagonist reservoir. |